Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan L Vennerstrom

Showing results (101-110 of 104) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 104 results.
ACS Infectious Diseases|September 11, 2023
Antimalarial Dibenzannulated Medium-Ring Keto LactamsRongguo Ren, Xiaofang Wang, Derek A Leas, et al.
Journal of Medicinal Chemistry|January 5, 2017
Structure-Activity Relationship of the Antimalarial Ozonide Artefenomel (OZ439)Yuxiang Dong, Xiaofang Wang, Sriraghavan Kamaraj, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2011
Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malariaSusan A Charman, Sarah Arbe-Barnes, Ian C Bathurst, et al.
Science Translational Medicine|February 23, 2022
Therapeutic efficacy of antimalarial drugs targeting DosRS signaling in <i>Mycobacterium abscessus</i>Juan Manuel Belardinelli, Deepshikha Verma, Wei Li, et al.
Pageof 11

Showing results (101-110 of 104) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 104 results.
ACS Infectious Diseases|September 11, 2023
Antimalarial Dibenzannulated Medium-Ring Keto LactamsRongguo Ren, Xiaofang Wang, Derek A Leas, et al.
Journal of Medicinal Chemistry|January 5, 2017
Structure-Activity Relationship of the Antimalarial Ozonide Artefenomel (OZ439)Yuxiang Dong, Xiaofang Wang, Sriraghavan Kamaraj, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2011
Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malariaSusan A Charman, Sarah Arbe-Barnes, Ian C Bathurst, et al.
Science Translational Medicine|February 23, 2022
Therapeutic efficacy of antimalarial drugs targeting DosRS signaling in <i>Mycobacterium abscessus</i>Juan Manuel Belardinelli, Deepshikha Verma, Wei Li, et al.
Pageof 11